Adenocarcinoma
Name | Preis | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Recombinant Human SRC Active GST-His | Anmelden | Recombinant Human SRC Active GST-His | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human TEK/TIE2 (aa 771-1124) Active GST-His | Anmelden | Recombinant Human TEK/TIE2 (aa 771-1124) Active GST-His | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human FGR (Met1-Thr529) Active GST-His | Anmelden | Recombinant Human FGR (Met1-Thr529) Active GST-His | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human BRAF (VE) Active GST-His | Anmelden | Recombinant Human BRAF (VE) Active GST-His | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human BRAF (wt) Active GST-His | Anmelden | Recombinant Human BRAF (wt) Active GST-His | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human CDK2/CCNE1 complex GST-His Active | Anmelden | Recombinant Human CDK2/CCNE1 complex GST-His Active | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human CDK2/CycA Kinase Complex GST-His Active | Anmelden | Recombinant Human CDK2/CycA Kinase Complex GST-His Active | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human EPH Receptor A4 Active GST-His | Anmelden | Recombinant Human EPH Receptor A4 Active GST-His | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human Neuregulin 1-beta | Anmelden | Recombinant Human Neuregulin 1-beta | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human Neuregulin 1-beta Animal Free | Anmelden | Recombinant Human Neuregulin 1-beta Animal Free | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human VEGF-121 | Anmelden | Recombinant Human VEGF-121 | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human FGR GST Active | Anmelden | Recombinant Human FGR GST Active | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human GAPDH (aa 1-335) | Anmelden | Recombinant Human GAPDH (aa 1-335) | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human Endogenous VEGFR-1, soluble | Anmelden | Recombinant Human Endogenous VEGFR-1, soluble | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human VEGFR-1 (D4), soluble | Anmelden | Recombinant Human VEGFR-1 (D4), soluble | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human VEGFR-1 / Fc Chimera, soluble | Anmelden | Recombinant Human VEGFR-1 / Fc Chimera, soluble | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human VEGFR-2 (D7), soluble | Anmelden | Recombinant Human VEGFR-2 (D7), soluble | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human VEGFR-3 Fc Chimera, soluble | Anmelden | Recombinant Human VEGFR-3 Fc Chimera, soluble | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human VEGFR-3 His-Tag, soluble | Anmelden | Recombinant Human VEGFR-3 His-Tag, soluble | ||||||||||||||||
|
||||||||||||||||||
Recombinant Equine VEGF 165 Animal Free | Anmelden | Recombinant Equine VEGF 165 Animal Free | ||||||||||||||||
|
||||||||||||||||||
Recombinant Equine VEGF 165 | Anmelden | Recombinant Equine VEGF 165 | ||||||||||||||||
|
||||||||||||||||||
Recombinant Equine VEGF 165 | Anmelden | Recombinant Equine VEGF 165 | ||||||||||||||||
|
||||||||||||||||||
Recombinant Equine VEGF 165 Animal Free | Anmelden | Recombinant Equine VEGF 165 Animal Free | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human Mothers Against Decapentaplegic Homolog 4 His | Anmelden | Recombinant Human Mothers Against Decapentaplegic Homolog 4 His | ||||||||||||||||
|
||||||||||||||||||
Recombinant Human VEGF 145 | Anmelden | Recombinant Human VEGF 145 | ||||||||||||||||
|